ChampionX saw the highest growth of 1.09% in patent filings in April and 2.49% in grants in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 1.09% and grants by 0.66%. GlobalData’s DataBook provides a comprehensive analysis of ChampionX‘s patent filings and grants. Buy the databook here.
ChampionX has been focused on protecting inventions in United States(US) with 21 publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 58% filings and 83% grants. The United States(US), World Intellectual Property Organization(WIPO), United Kingdom(GB), and European Patent Office(EPO) patent Office are among the top ten patent offices where ChampionX is filings its patents. Among the top granted patent authorities, ChampionX has 83% of its grants in United States(US), 8% in European Patent Office(EPO) and 8% in Canada(CA).
NOK could be the strongest competitor for ChampionX
Patents related to nanomedicine and subsea lead ChampionX's portfolio
ChampionX has the highest number of patents in nanomedicine followed by, subsea and emissions reduction. For nanomedicine, nearly 31% of patents were filed and 40% of patents were granted in Q2 2024.
Wells related patents lead ChampionX portfolio followed by production, and petrochemicals
ChampionX has highest number of patents in wells followed by production, petrochemicals, gas processing, and refining. For wells, nearly 43% of patents were filed and 38% of patents were granted in Q2 2024.
For comprehensive analysis of ChampionX's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.